| Targeting alternatively spliced isoforms of alpha-synuclein as a disease modifying therapy for Parkinson's disease | Life Sciences & Biotechnology | 2024 | 2027 |
| Understanding the role of PARP16 in the development of cardiac lipotoxicity | Life Sciences & Biotechnology | 2024 | 2027 |
| Understanding the regulation of gap junction protein Connexin 43 in Murine-beta-Coronavirus, MHV induced acute and chronic phase inflammation by combining TNF-alpha, IL-10 and TGF- beta signalling triad. | Life Sciences & Biotechnology | 2024 | 2027 |
| Functional characterization of Inflammatory Bowel Disease GWAs implicated protein C1orf53 | Life Sciences & Biotechnology | 2024 | 2027 |
| Development of nanotherapeutic systems for siRNA or AsO based inhibition of sNHG5 lncRNA in Pancreatic Ductal Adenocarcinoma | Life Sciences & Biotechnology | 2024 | 2027 |
| Hydrogel-forming Microneedle arrays for Non Invasive Point-of-Care Testing of Neonatal sepsis. | Life Sciences & Biotechnology | 2024 | 2027 |
| Unraveling the cardiac function of m6A RNA methylation reader protein YTHDF3 | Life Sciences & Biotechnology | 2024 | 2027 |
| Development and characterization of organotypic culture model as a tool to investigate demyelination disorder caused by neurotropic viruses | Life Sciences & Biotechnology | 2024 | 2027 |
| Understanding the role of PIM kinases in regulating sclerostin expression, secretion and function: Hunt for an alternate target for the treatment of osteoporosis | Life Sciences & Biotechnology | 2024 | 2027 |
| Novel beta3-adrenergic agonists as senolytics and insulin sensitizers: studies in adipose tissue of metabolic dyshomeostasis model systems | Life Sciences & Biotechnology | 2024 | 2027 |